Dawei Zhu

473 total citations
22 papers, 353 citations indexed

About

Dawei Zhu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Dawei Zhu has authored 22 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Dawei Zhu's work include Ferroptosis and cancer prognosis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Renal cell carcinoma treatment (4 papers). Dawei Zhu is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Renal cell carcinoma treatment (4 papers). Dawei Zhu collaborates with scholars based in China, Japan and Taiwan. Dawei Zhu's co-authors include Lujun Chen, Huimin Wang, Xiaosong Ge, Jing Sun, Fengming Wang, Dong Hua, Yong Mao, Meilin Liao, Jingting Jiang and Jinghang Li and has published in prestigious journals such as Archives of Biochemistry and Biophysics, European Journal of Pharmacology and Medicine.

In The Last Decade

Dawei Zhu

22 papers receiving 348 citations

Peers

Dawei Zhu
Comparison fields: 5 of 68
  • Molecular Biology 180
  • Oncology 126
  • Cancer Research 106
  • Pulmonary and Respiratory Medicine 77
  • Immunology 74
Replace Anna Hester with:
Anna Hester Germany
Yan Dai China
Shuijie Li China
Yixiao Xiong China
Yutong Meng China
Chengdong Liu China
Lina Qi China
Lu Wu China
Qiaohong Qin China
Yuchao Dong China
Anna Hester Germany View profile →
Citations per field, relative to Dawei Zhu
Dawei Zhu · 1×
Citations per year, relative to Dawei Zhu
Dawei Zhu · 1×

Countries citing papers authored by Dawei Zhu

Since Specialization
Citations

This map shows the geographic impact of Dawei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Zhu more than expected).

Fields of papers citing papers by Dawei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Zhu. The network helps show where Dawei Zhu may publish in the future.

Co-authorship network of co-authors of Dawei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Zhu. A scholar is included among the top collaborators of Dawei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Zhu. Dawei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 4
3 6
4 4
5 21
6 4
7 9
8 14
9 34
10 14
11
Aldolase A promotes cell proliferation and cisplatin resistance via the EGFR pathway in gastric cancer.
6
12 7
13 32
14 5
15 7
16 22
17 25
18 2
19 68
20 51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026